These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease. McKnight JL; Cen H; Riddler SA; Breinig MC; Williams PA; Ho M; Joseph PS Leuk Lymphoma; 1994 Sep; 15(1-2):9-16. PubMed ID: 7858507 [TBL] [Abstract][Full Text] [Related]
3. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice. Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus induced lymphoproliferative tumors in severe combined immunodeficient mice are oligoclonal. Pisa P; Cannon MJ; Pisa EK; Cooper NR; Fox RI Blood; 1992 Jan; 79(1):173-9. PubMed ID: 1309425 [TBL] [Abstract][Full Text] [Related]
6. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation. Montone KT; Litzky LA; Wurster A; Kaiser L; Bavaria J; Kotloff R; Palevsky H; Pietra GG; Tomaszewski JE Surgery; 1996 May; 119(5):544-51. PubMed ID: 8619211 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease. Perera SM; Thomas JA; Burke M; Crawford DH J Pathol; 1998 Feb; 184(2):177-84. PubMed ID: 9602709 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes. Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation. Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136 [TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. Armes JE; Angus P; Southey MC; Battaglia SE; Ross BC; Jones RM; Venter DJ Cancer; 1994 Nov; 74(9):2436-41. PubMed ID: 7922997 [TBL] [Abstract][Full Text] [Related]
11. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. Delecluse HJ; Kremmer E; Rouault JP; Cour C; Bornkamm G; Berger F Am J Pathol; 1995 May; 146(5):1113-20. PubMed ID: 7747805 [TBL] [Abstract][Full Text] [Related]
12. T gamma/delta hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder: a case report. Kraus MD; Crawford DF; Kaleem Z; Shenoy S; MacArthur CA; Longtine JA Cancer; 1998 Mar; 82(5):983-92. PubMed ID: 9486591 [TBL] [Abstract][Full Text] [Related]
13. Expansion in scid mice of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease biopsy material. Johannessen I; Perera SM; Gallagher A; Hopwood PA; Thomas JA; Crawford DH J Gen Virol; 2002 Jan; 83(Pt 1):173-178. PubMed ID: 11752714 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients. Strazzabosco M; Corneo B; Iemmolo RM; Menin C; Gerunda G; Bonaldi L; Merenda R; Neri D; Poletti A; Montagna M; Del Mistro A; Faccioli AM; D'Andrea E J Hepatol; 1997 Apr; 26(4):926-34. PubMed ID: 9126809 [TBL] [Abstract][Full Text] [Related]
15. Growth of Epstein-Barr virus-associated B-lymphoproliferative disease tissue in a severe combined immunodeficient mouse. Perera SM; Johannessen I; Thomas JA; Brooks LA; Jobe JN; Crawford DH; Radley-Smith R; Phillips M Blood; 1996 Aug; 88(3):1123-5. PubMed ID: 8704225 [No Abstract] [Full Text] [Related]
16. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Nelson BP; Nalesnik MA; Bahler DW; Locker J; Fung JJ; Swerdlow SH Am J Surg Pathol; 2000 Mar; 24(3):375-85. PubMed ID: 10716151 [TBL] [Abstract][Full Text] [Related]
17. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055 [TBL] [Abstract][Full Text] [Related]
18. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus. Lones MA; Shintaku IP; Weiss LM; Thung SN; Nichols WS; Geller SA Hum Pathol; 1997 May; 28(5):533-9. PubMed ID: 9158700 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation. Raymond E; Tricottet V; Samuel D; Reynès M; Bismuth H; Misset JL Cancer; 1995 Oct; 76(8):1344-51. PubMed ID: 8620407 [TBL] [Abstract][Full Text] [Related]
20. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease. Montone KT; Hodinka RL; Salhany KE; Lavi E; Rostami A; Tomaszewski JE Mod Pathol; 1996 Jun; 9(6):621-30. PubMed ID: 8782198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]